Tactile Systems Technology Inc
NASDAQ:TCMD
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
607.4m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
185.4B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.6B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.1B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Tactile Systems Technology Inc is 50.8%, which is above its 3-year median of 50.3%.
Over the last 3 years, Tactile Systems Technology Inc’s Gross Margin has increased from 48.7% to 50.8%. During this period, it reached a low of 48.7% on Dec 31, 2022 and a high of 51.4% on Sep 30, 2024.
